Luminai
Deployment Strategist
San Francisco or New York. Posted 9 months ago
The role
The Deployment Strategist owns how Luminai is deployed, adopted, and scaled inside customer environments. You will translate complex healthcare workflows into production-ready deployments by working with Product, Engineering, and Customer teams.
What you will do
- Own end-to-end deployments for Luminai customers from post-sale handoff through launch and stabilization
- Understand customer workflows, constraints, and operating models to design deployment strategies
- Translate customer requirements into execution plans, timelines, and success criteria
- Coordinate with Product and Engineering to scope work, sequence dependencies, and unblock launches
- Partner with customer stakeholders across Ops, IT, and leadership to drive alignment and accountability
- Identify patterns across deployments and feed insights back into product improvements
- Manage risks proactively and drive resolution
- Run communication cadences with customers including status updates, milestones, and escalation paths
- Help build and refine deployment playbooks, templates, and processes
Required qualifications
- 3–6+ years of experience in deployment, implementation, solutions, technical program management, or a similar customer-facing role
- Experience owning complex, multi-stakeholder rollouts in production environments
- Strong systems thinking and comfort working with technical concepts (APIs, integrations, workflows)
- Ability to translate ambiguous requirements into concrete plans and outcomes
- Excellent communication skills across technical and non-technical audiences
- Strong organizational skills with the ability to manage multiple parallel initiatives
Nice to have
- Experience deploying healthcare software
- Experience deploying AI-driven products
- Experience deploying enterprise platforms
About the company
Luminai provides an integrated intelligence layer to automate manual healthcare workflows. The company has raised $60M in funding and is backed by investors including Peak XV Partners, Define Ventures, General Catalyst, and Y Combinator.